Bumetanide
- Generic Name
- Bumetanide
- Brand Names
- Bumex, Burinex
- Drug Type
- Small Molecule
- Chemical Formula
- C17H20N2O5S
- CAS Number
- 28395-03-1
- Unique Ingredient Identifier
- 0Y2S3XUQ5H
- Background
Bumetanide is a sulfamyl diuretic.
- Indication
For the treatment of edema associated with congestive heart failure, hepatic and renal disease including the nephrotic syndrome.
- Associated Conditions
- Edema
Efficiency of Bumetanide in Autistic Children
- First Posted Date
- 2010-03-02
- Last Posted Date
- 2011-12-21
- Lead Sponsor
- University Hospital, Brest
- Target Recruit Count
- 60
- Registration Number
- NCT01078714
- Locations
- 🇫🇷
DUPIN, Vannes, France
🇫🇷Lemonnier, Brest, France
🇫🇷Chevreuil, Rennes, France
Study to Evaluate the Potential Pharmacokinetic Interaction and Pharmacodynamic Effects on Renal Parameters of Bumetanide (1mg) and Dapagliflozin (10 mg) When Co-administered in Healthy Subjects
- First Posted Date
- 2009-07-02
- Last Posted Date
- 2016-10-17
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 42
- Registration Number
- NCT00930865
- Locations
- 🇺🇸
Ppd Development, Lp, Austin, Texas, United States
Pilot Study of Bumetanide for Newborn Seizures
- First Posted Date
- 2009-01-28
- Last Posted Date
- 2020-12-17
- Lead Sponsor
- Soul, Janet , M.D.
- Target Recruit Count
- 43
- Registration Number
- NCT00830531
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Tufts Floating Hospital for Children at Tufts Medical Center, Boston, Massachusetts, United States
🇺🇸Boston Children's Hospital, Boston, Massachusetts, United States
Bumetanide Versus Furosemide in Heart Failure
- First Posted Date
- 2006-09-07
- Last Posted Date
- 2014-03-27
- Lead Sponsor
- Lawson Health Research Institute
- Registration Number
- NCT00372762
- Locations
- 🇨🇦
University Hospital, London Health Sciences Centre, London, Ontario, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath